药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zuclopenthixol
Rovalpituzumab Tesirine
The risk or severity of adverse effects can be increased when Rovalpituzumab Tesirine is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Robatumumab
The risk or severity of adverse effects can be increased when Robatumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Milatuzumab
The risk or severity of adverse effects can be increased when Milatuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Bimekizumab
The risk or severity of adverse effects can be increased when Bimekizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Sacituzumab govitecan
The risk or severity of adverse effects can be increased when Sacituzumab govitecan is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Ozanezumab
The risk or severity of adverse effects can be increased when Ozanezumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Clazakizumab
The risk or severity of adverse effects can be increased when Clazakizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Amatuximab
The risk or severity of adverse effects can be increased when Amatuximab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Rontalizumab
The risk or severity of adverse effects can be increased when Rontalizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Depatuxizumab
The risk or severity of adverse effects can be increased when Depatuxizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Concizumab
The risk or severity of adverse effects can be increased when Concizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Crotedumab
The risk or severity of adverse effects can be increased when Crotedumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Naptumomab Estafenatox
The risk or severity of adverse effects can be increased when Naptumomab Estafenatox is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Ecromeximab
The risk or severity of adverse effects can be increased when Ecromeximab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Abituzumab
The risk or severity of adverse effects can be increased when Abituzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Sifalimumab
The risk or severity of adverse effects can be increased when Sifalimumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Demcizumab
The risk or severity of adverse effects can be increased when Demcizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Carlumab
The risk or severity of adverse effects can be increased when Carlumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Intetumumab
The risk or severity of adverse effects can be increased when Intetumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Ibalizumab
The risk or severity of adverse effects can be increased when Ibalizumab is combined with Trastuzumab deruxtecan.